The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Open accessAbstract
BACKGROUND: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). OBJECTIVES: The objectives of this review are to estimate the incidence and prevalence of selected comorbid psychiatric disorders in MS and evaluate the quality of included studies. METHODS: We searched the PubMed, PsychInfo, SCOPUS, and Web of Knowledge databases and reference lists of retrieved articles. Abstracts were screened for relevance by two independent reviewers, followed by full-text review. Data were abstracted by one reviewer, and verified by a second reviewer. Study quality was evaluated using a standardized tool. For population-based studies we assessed heterogeneity quantitatively using the I² statistic, and conducted meta-analyses. RESULTS: We included 118 studies in this review. Among population-based studies, the prevalence of anxiety was 21.9% (95% CI: 8.76%-35.0%), while it was 14.8% for alcohol abuse, 5.83% for bipolar disorder, 23.7% (95% CI: 17.4%-30.0%) for depression, 2.5% for substance abuse, and 4.3% (95% CI: 0%-10.3%) for psychosis. CONCLUSION: This review confirms that psychiatric comorbidity, particularly depression and anxiety, is common in MS. However, the incidence of psychiatric comorbidity remains understudied. Future comparisons across studies would be enhanced by developing a consistent approach to measuring psychiatric comorbidity, and reporting of age-, sex-, and ethnicity-specific estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A comprehensive systematic review of 118 studies on psychiatric comorbidities in MS found that psychiatric comorbidities were common; in particular, the prevalence of diagnosed anxiety and depression were estimated at 21.9 and 23.7%, respectively [53].”
From Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap (2022) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“MS patients show increased levels of anxiety and depression compared to healthy participants, and these conditions affect more than 20% of patients [8,21,22,23].”
From Biopsychosocial Correlates of Quality of Life in Multiple Sclerosis Patients (2022) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Marrie, R., Cohen, J., Stüve, O., Trojano, M., Sørensen, P., Reingold, S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis · doi:10.1177/1352458514564491 · Cited by 762
Self-citationNeyeloff, J. L., Fuchs, S. C. P. C., & Moreira, L. B. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-52 · Cited by 731
Depressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
Depression and multiple sclerosis
Sadovnick, A. D., Remick, R. A., Allen, J. B., Swartz, E. S., Yee, I. M. L., Eisen, K., Farquhar, R., Hashimoto, S. A., Hooge, J. P., Kastrukoff, L. F., et al. (1996) · Neurology · doi:10.1212/wnl.46.3.628 · Cited by 536
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700511 · Cited by 506
Quality of life in patients with multiple sclerosis
Janardhan, V., & Bakshi, R. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00312-x · Cited by 489
Lobentanz, I. S., Asenbaum, S., Vass, K., Sauter, C., Klosch, G., Kollegger, H., Kristoferitsch, W., & Zeitlhofer, J. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00257.x · Cited by 439
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424
Cited by
Sorted by citations
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
A systematic review of reviews on the prevalence of anxiety disorders in adult populations
Remes, O., Brayne, C., van der Linde, R., & Lafortune, L. (2016) · Brain and Behavior · doi:10.1002/brb3.497 · Cited by 802
Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis
Boeschoten, R. E., Braamse, A. M. J., Beekman, A. T. F., Cuijpers, P., van Oppen, P., Dekker, J., & Uitdehaag, B. M. J. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.067 · Cited by 713
Depression and anxiety in patients with Inflammatory Bowel Disease: a systematic review
Neuendorf, R., Harding, A., Stello, N., Hanes, D., & Wahbeh, H. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.06.001 · Cited by 561
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Marrie, R., Cohen, J., Stüve, O., Trojano, M., Sørensen, P., Reingold, S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis · doi:10.1177/1352458514564491 · Cited by 762
Self-citationImmune and neuroendocrine mechanisms of stress vulnerability and resilience
Ménard, C., Pfau, M. L., Hodes, G. E., & Russo, S. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.90 · Cited by 374
Depression in multiple sclerosis
Patten, S. B., Marrie, R. A., & Carta, M. G. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1322555 · Cited by 262
Self-citationComorbidity in Multiple Sclerosis
Magyari, M., & Sørensen, P. S. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00851 · Cited by 211
Fiest, K. M., Walker, J. R., Bernstein, C. N., Graff, L. A., Zarychanski, R., Abou-Setta, A. M., Patten, S. B., Sareen, J., Bolton, J. M., Marriott, J. J., et al. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.10.004 · Cited by 198
Self-citationBortolato, B., Köhler, C. A., Εvangelou, Ε., Caballero, J. L., Solmi, M., Stubbs, B., Belbasis, L., Pacchiarotti, I., Kessing, L. V., Berk, M., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12490 · Cited by 204
Increased incidence of psychiatric disorders in immune-mediated inflammatory disease
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A. G., Lix, L. M., Hitchon, C. A., El-Gabalawy, R. M., et al. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.07.015 · Cited by 183
Self-citationNeuropsychiatric Symptoms of Multiple Sclerosis: State of the Art
Silveira, C., Guedes, R., Maia, D., Curral, R., & Coelho, R. C. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.0106 · Cited by 181
Prodromal symptoms of multiple sclerosis in primary care
Disanto, G., Zecca, C., MacLachlan, S., Sacco, R., Handunnetthi, L., Meier, U., Simpson, A., McDonald, L., Rossi, A., Benkert, P., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25247 · Cited by 172
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis
Rossi, S., Studer, V., Motta, C., Polidoro, S., Perugini, J., Macchiarulo, G., Giovannetti, A. M., Gutierrez, L. P., Calò, A., Colonna, I., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004411 · Cited by 175
Marrie, R. A., Zhang, L., Lix, L. M., Graff, L. A., Walker, J. R., Fisk, J. D., Patten, S. B., Hitchon, C. A., Bolton, J. M., Sareen, J., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.12.007 · Cited by 169
Fatigue in multiple sclerosis – Insights into evaluation and management
Ayache, S. S., & Chalah, M. A. (2017) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2017.02.004 · Cited by 163
The Multiple Sclerosis Care Unit
Sørensen, P. S., Giovannoni, G., Montalbán, X., Thalheim, C., Zaratin, P., & Comı, G. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518807082 · Cited by 158
Differences in the burden of psychiatric comorbidity in MS vs the general population
Marrie, R. A., Fisk, J. D., Tremlett, H. L., Wolfson, C. M., Warren, S., Tennakoon, A., Leung, S., & Patten, S. B. (2015) · Neurology · doi:10.1212/wnl.0000000000002174 · Cited by 150
Self-citationMarck, C. H., Neate, S. L., Taylor, K. L., Weiland, T. J., & Jelinek, G. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148573 · Cited by 146
Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis
Ayache, S. S., Palm, U., Chalah, M. A., Al-ani, T., Brignol, A., Abdellaoui, M., Dimitri, D., Sorel, M., Créange, A., & Lefaucheur, J. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00147 · Cited by 140
The hippocampus in multiple sclerosis
Rocca, M. A., Barkhof, F., Luca, J. D., Frisén, J., Geurts, J. J. G., Hulst, H. E., Sastre‐Garriga, J., Filippi, M., Barkhof, F., Ciccarelli, O., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30309-0 · Cited by 134
Sex differences in comorbidity at diagnosis of multiple sclerosis
Marrie, R. A., Patten, S. B., Tremlett, H. L., Wolfson, C. M., Warren, S., Svenson, L. W., Jetté, N., Fisk, J. D., For the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis, CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis, et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002481 · Cited by 126
Self-citationFive years before multiple sclerosis onset: Phenotyping the prodrome
Wijnands, J. M. A., Zhu, F., Kingwell, E., Zhao, Y.-S., Ekuma, O., Lu, X., Evans, C., Fisk, J., Marrie, R., & Tremlett, H. (2018) · Multiple Sclerosis · doi:10.1177/1352458518783662 · Cited by 119
Self-citationPeres, D. S., Rodrigues, P., Viero, F. T., Frare, J. M., Kudsi, S. Q., Meira, G. M., & Trevisan, G. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100484 · Cited by 134
The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases
Peppas, S., Pansieri, C., Piovani, D., Danese, S., Peyrin‐Biroulet, L., Tsantes, A. G., Brunetta, E., Tsantes, A. Ε., & Bonovas, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030377 · Cited by 116
Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders
Whitehouse, C. E., Fisk, J. D., Bernstein, C. N., Berrigan, L. I., Bolton, J. M., Graff, L. A., Hitchon, C. A., Marriott, J. J., Peschken, C. A., Sareen, J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006854 · Cited by 112
Self-citationFatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions
Brenner, P., & Piehl, F. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12648 · Cited by 123
Effects of left DLPFC versus right PPC tDCS on multiple sclerosis fatigue
Chalah, M. A., Riachi, N. J., Ahdab, R., Mhalla, A., Abdellaoui, M., Créange, A., Lefaucheur, J., & Ayache, S. S. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.015 · Cited by 106
Behavioural phenotypes in the cuprizone model of central nervous system demyelination
Sen, M. K., Mahns, D. A., Coorssen, J. R., & Shortland, P. J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.008 · Cited by 101
Langeskov‐Christensen, M., Bisson, E. J., Finlayson, M. L., & Dalgas, U. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.002 · Cited by 105
Multiple sclerosis and suicide
Feinstein, A., & Pavisian, B. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517702553 · Cited by 99
Fitzgerald, K. C., Smith, M. D., Kim, S., Sotirchos, E. S., Kornberg, M. D., Douglas, M., Nourbakhsh, B., Graves, J., Rattan, R., Poisson, L., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100424 · Cited by 102
Henry, A., Tourbah, A., Camus, G., Deschamps, R., Mailhan, L., Castex, C., Gout, O., & Montreuil, M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.09.039 · Cited by 95
Simpson, R., Mair, F. S., & Mercer, S. W. (2017) · BMC Neurology · doi:10.1186/s12883-017-0880-8 · Cited by 95
Hauer, L., Perneczky, J., & Sellner, J. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10107-y · Cited by 98
Tzeng, N., Chang, H., Chung, C., Kao, Y., Chang, C.-C., Yeh, H., Chiang, W.-S., Chou, Y., Chang, S., & Chien, W. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00133 · Cited by 85
Social neuroscience: undoing the schism between neurology and psychiatry
Ibáñez, A. M., García, A. M., Esteves, S., Yoris, A., Muñoz, É., Reynaldo, L., Pietto, M. L., Adolfi, F., & Manes, F. F. (2016) · Social Neuroscience · doi:10.1080/17470919.2016.1245214 · Cited by 86
Motl, R. W., Mowry, E. M., Ehde, D. M., LaRocca, N. G., Smith, K. E., Costello, K., Shinto, L. H., Ng, A. V., Sullivan, A. B., Giesser, B. S., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516687404 · Cited by 88
Impact of Shared Decision Making on Disease-Modifying Drug Adherence in Multiple Sclerosis
Ben‐Zacharia, A. B., Adamson, M., Boyd, A., Hardeman, P., Smrtka, J., Walker, B. D., & Walker, T. (2018) · International Journal of MS Care · doi:10.7224/1537-2073.2017-070 · Cited by 83
A unified model of the pathophysiology of bipolar disorder
Magioncalda, P., & Martino, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01091-4 · Cited by 98
Sandi, D., Rudisch, T., Füvesi, J., Fricska‐Nagy, Z., Huszka, H., Biernacki, T., Langdon, D. W., Langane, É., Vécsei, L., & Bencsik, K. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.07.006 · Cited by 82
Recommendations for observational studies of comorbidity in multiple sclerosis
Marrie, R. A., Miller, A., Sormani, M. P., Thompson, A. J., Waubant, E. L., Trojano, M., O'Connor, P. W., Fiest, K. M., Reider, N., Reingold, S. C., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002474 · Cited by 82
Self-citationSedentary behaviour in people with multiple sclerosis: Is it time to stand up against MS?
Zanten, J. V., Pilutti, L. A., Duda, J. L., & Motl, R. W. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516644340 · Cited by 82
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
Bruno, A., Dolcetti, E., Rizzo, F. R., Fresegna, D., Musella, A., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bullitta, S., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00169 · Cited by 87
Online meditation training for people with multiple sclerosis: a randomized controlled trial
Cavalera, C., Rovaris, M., Mendozzi, L., Pugnetti, L., Garegnani, M., Castelnuovo, G., Molinari, E., & Pagnini, F. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458518761187 · Cited by 74
Psychiatric disorders in multiple sclerosis
Sparaco, M., Lavorgna, L., & Bonavita, S. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09426-6 · Cited by 79
Neuropsychological correlates of theory of mind deficits in patients with multiple sclerosis.
Raimo, S., Trojano, L., Pappacena, S., Alaia, R., Spitaleri, D. L. A., Grossi, D., & Santangelo, G. (2017) · Neuropsychology · doi:10.1037/neu0000372 · Cited by 76
Veauthier, C., Hasselmann, H., Gold, S. M., & Paul, F. (2016) · EPMA Journal · doi:10.1186/s13167-016-0073-3 · Cited by 71
Treatment choices and neuropsychological symptoms of a large cohort of early MS
von Bismarck, O., Dankowski, T., Ambrosius, B., Heßler, N., Antony, G., Ziegler, A., Hoshi, M., Aly, L., Luessi, F., Groppa, S., et al. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000446 · Cited by 69
Patrick, S., & Connick, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0197943 · Cited by 67
Social support in multiple sclerosis: associations with quality of life, depression, and anxiety
Ratajska, A., Glanz, B. I., Chitnis, T., Weiner, H. L., & Healy, B. C. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110252 · Cited by 66
Multiple sclerosis and aging: comorbidity and treatment challenges
Ostolaza, A., Corroza, J., & Ayuso, T. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102815 · Cited by 66
The prevalence of anxiety and associated factors in persons with multiple sclerosis
Pham, T., Jetté, N., Bulloch, A. G. M., Burton, J. M., Wiebe, S., & Patten, S. B. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.11.003 · Cited by 64
Marrie, R. A., Patten, S. B., Berrigan, L. I., Tremlett, H. L., Wolfson, C. M., Warren, S., Leung, S., Fiest, K. M., McKay, K. A., Fisk, J. D., et al. (2017) · International Journal of MS Care · doi:10.7224/1537-2073.2016-110 · Cited by 65
Self-citationAssessing association of comorbidities with treatment choice and persistence in MS
Laroni, A., Signori, A., Maniscalco, G. T., Lanzillo, R., Russo, C. V., Binello, E., Fermo, S. L., Repice, A., Annovazzi, P. O. L., Bonavita, S., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004686 · Cited by 65
Anxiety in Multiple Sclerosis: psychometric properties of the State-Trait Anxiety Inventory
Santangelo, G., Sacco, R., Siciliano, M., Bisecco, A., Muzzo, G., Docimo, R., Stefano, M. D., Bonavita, S., Lavorgna, L., Tedeschi, G., et al. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12564 · Cited by 66
Solaro, C. M., Trabucco, E., Signori, A., Martinelli, V., Radaelli, M., Centonze, D., Rossi, S., Grasso, M. G., Clemenzi, A., Bonavita, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160261 · Cited by 64
Walzl, D., Solomon, A. J., & Stone, J. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10436-6 · Cited by 62
Depression in multiple sclerosis: Is one approach for its management enough?
Jones, C. D., Motl, R. W., & Sandroff, B. M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102904 · Cited by 64
Grace, P. M., Loram, L. C., Christianson, J. P., Strand, K. A., Flyer-Adams, J. G., Penzkover, K. R., Forsayeth, J., van Dam, A., Mahoney, M. J., Maier, S. F., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.012 · Cited by 62
Fatigue and Comorbidities in Multiple Sclerosis
Fiest, K. M., Fisk, J. D., Patten, S. B., Tremlett, H. L., Wolfson, C. M., Warren, S., McKay, K. A., Berrigan, L. I., Marrie, R. A., & for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS) (2016) · International Journal of MS Care · doi:10.7224/1537-2073.2015-070 · Cited by 63
Self-citationPrevalence of neuropathic pain in early multiple sclerosis
Heitmann, H., Biberacher, V., Tiemann, L., Buck, D., Loleit, V., Selter, R., Knier, B., Tölle, T. R., Mühlau, M., Berthele, A., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515613643 · Cited by 59
Wellness and the Role of Comorbidities in Multiple Sclerosis
Moss, B. P., Rensel, M. R., & Hersh, C. M. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0563-6 · Cited by 61
Hoogerwerf, A., Bol, Y., Lobbestael, J., Hupperts, R., & Heugten, C. (2017) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-2237 · Cited by 58
Neurophysiological, radiological and neuropsychological evaluation of fatigue in multiple sclerosis
Chalah, M. A., Kauv, P., Créange, A., Hodel, J., Lefaucheur, J., & Ayache, S. S. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.12.029 · Cited by 58
McKay, K. A., Tremlett, H. L., Patten, S. B., Fisk, J. D., Evans, C. D., Fiest, K. M., Campbell, T. L., Marrie, R. A., & for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS) (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516657440 · Cited by 59
Self-citationDissociable cognitive patterns related to depression and anxiety in multiple sclerosis
Leavitt, V. M., Brandstadter, R., Fabian, M. T., Sand, I. K., Klineova, S., Krieger, S. C., Lewis, C., LUBLIN, F. D., Miller, A., Pelle, G., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519860319 · Cited by 58
For the CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease, Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A. G., Lix, L. M., Hitchon, C. A., et al. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2958-1 · Cited by 55
Self-citationMental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder
Turner, A. P., Alschuler, K. N., Hughes, A. J., Beier, M. L., Haselkorn, J. K., Sloan, A. P., & Ehde, D. M. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0706-x · Cited by 55
Arima, Y., Ohki, T., Nishikawa, N., Higuchi, K., Ota, M., Tanaka, Y., Nio‐Kobayashi, J., Elfeky, M., Sakai, R., Mori, Y., et al. (2017) · eLife · doi:10.7554/elife.25517 · Cited by 54
Quality of life in patients with multiple sclerosis: A study with patients and caregivers
Santos, M., Sousa, C., Pereira, M., & Pereira, M. G. (2019) · Disability and health journal · doi:10.1016/j.dhjo.2019.03.007 · Cited by 88
Marrie, R. A., Graff, L. A., Walker, J. R., Fisk, J. D., Patten, S. B., Hitchon, C. A., Lix, L. M., Bolton, J. M., Sareen, J., Katz, A., et al. (2018) · JMIR Research Protocols · doi:10.2196/resprot.8794 · Cited by 56
Self-citationCoping with multiple sclerosis-the role of social support
Rommer, P. S., Sühnel, A., König, N., & Zettl, U. K. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12673 · Cited by 52
Hyarat, S. Y., Subih, M., Rayan, A., Salami, I., & Harb, A. (2019) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2018.08.006 · Cited by 51
Carletto, S., Tesio, V., Borghi, M., Francone, D., Scavelli, F., Bertino, G., Malucchi, S., Bertolotto, A., Oliva, F., Torta, R., et al. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.02083 · Cited by 49
Multiple sclerosis and risk of attempted and completed suicide – a cohort study
Brenner, P., Burkill, S. M., Jokinen, J., Hillert, J. A., Bahmanyar, S., & Montgomery, S. (2016) · European Journal of Neurology · doi:10.1111/ene.13029 · Cited by 50
Nakazawa, K., Noda, T., Ichikura, K., Okamoto, T., Takahashi, Y., Yamamura, T., & Nakagome, K. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.08.023 · Cited by 50
Liu, Y., & Tang, X.-Q. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00451 · Cited by 39
Role of Monocyte-Derived MicroRNA106b∼25 in Resilience to Social Stress
Pfau, M. L., Menard, C., Cathomas, F., Desland, F., Kana, V., Chan, K. L., Shimo, Y., LeClair, K., Flanigan, M. E., Aleyasin, H., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.02.023 · Cited by 46
Ramezani, N., Ashtari, F., Abdi, E., Ghaderi, K., Hosseini, S. M., Naeini, M. K., Rajabi, F., & Adibi, I. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102798 · Cited by 48
Quality of life and coping strategies in Lebanese multiple sclerosis patients: a pilot study
Farran, N., Ammar, D., & Darwish, H. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.12.003 · Cited by 42
Nathoo, N., & Mackie, A. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.10.004 · Cited by 48
Chou, I., Kuo, C., Tănăsescu, R., Tench, C. R., Tiley, C. G., Constantinescu, C. S., & Whitehouse, W. P. (2019) · European Journal of Neurology · doi:10.1111/ene.14040 · Cited by 50
Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models
Stamoula, Ε., Siafis, S., Dardalas, I., Ainatzoglou, A., Matsas, A., Athanasiadis, T., Sardeli, C., Stamoulas, K., & Papazisis, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.677879 · Cited by 49
The varieties of psychosis in multiple sclerosis: A systematic review of cases
Camara-Lemarroy, C. R., Ibarra-Yruegas, B. E., Rodríguez‐Gutiérrez, R., Morales, I. B., Ionete, C., & Riskind, P. N. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.12.012 · Cited by 43
Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints
Wallis, O. C., Bol, Y., Köhler, S., & Heugten, C. M. V. (2019) · Acta Neurologica Scandinavica · doi:10.1111/ane.13191 · Cited by 43
Maggio, M. G., Cuzzola, M. F., Latella, D., Impellizzeri, F., Todaro, A., Rao, G., Manuli, A., & Calabrò, R. S. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102560 · Cited by 44
Identification and management of subclinical disease activity in early multiple sclerosis: a review
Ontaneda, D., Chitnis, T., Rammohan, K. W., & Obeidat, A. Z. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12021-5 · Cited by 47
McKay, K. A., Tremlett, H. L., Fisk, J. D., Patten, S. B., Fiest, K. M., Berrigan, L. I., Marrie, R. A., & for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS) (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515599073 · Cited by 42
Self-citationAutoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis
Zivadinov, R., Raj, B., Ramanathan, M. K., Teter, B. E., Durfee, J., Dwyer, M. G., Bergsland, N., Kolb, C., Hojnacki, D. W., Benedict, R. H. B., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4681 · Cited by 42
Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7
Sato‐Kasai, M., Kato, T. A., Ohgidani, M., Mizoguchi, Y., Sagata, N., Inamine, S., Horikawa, H., Hayakawa, K., Shimokawa, N., Kyuragi, S., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.08.022 · Cited by 46
Workman, C. D., Kamholz, J. A., & Rudroff, T. (2019) · Brain stimulation · doi:10.1016/j.brs.2019.09.012 · Cited by 42
Heitmann, H., Haller, B., Tiemann, L., Mühlau, M., Berthele, A., Tölle, T. R., Salmen, A., Ambrosius, B., Bayas, A., Asseyer, S., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000001767 · Cited by 47
Third wave cognitive behavioural therapies for people with multiple sclerosis: a scoping review
Zarotti, N., Eccles, F., Broyd, A., Longinotti, C., Mobley, A., & Simpson, J. (2023) · Disability and Rehabilitation · doi:10.1080/09638288.2022.2069292 · Cited by 40
Sandi, D., Biernacki, T., Szekeres, D., Füvesi, J., Kincses, Z. T., Rózsa, C., Mátyás, K., Kása, K., Matolcsi, J., Zboznovits, D., et al. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.06.017 · Cited by 40
Menculini, G., Chipi, E., Paoletti, F. P., Gaetani, L., Nigro, P., Simoni, S., Mancini, A., Tambasco, N., Filippo, M. D., Tortorella, A. A. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094440 · Cited by 44
Alsaadi, T. M., Hammasi, K. E., Shahrour, T. M., Shakra, M., Turkawi, L., Mudhafar, A., Diab, L., & Raoof, M. (2015) · Multiple Sclerosis International · doi:10.1155/2015/487159 · Cited by 41
Hasselmann, H., Bellmann–Strobl, J., Ricken, R., Oberwahrenbrock, T., Rose, M., Otte, C., Adli, M., Paul, F., Brandt, A. U., Finke, C., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515622826 · Cited by 41
Determinants and incidence of depression in multiple sclerosis: A prospective cohort study.
Berzins, S., Bulloch, A., Burton, J., Dobson, K., Fick, G. H., & Patten, S. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.06.012 · Cited by 38
Weiland, T. J., Livera, A. M. D., Brown, C. R., Jelinek, G. A., Aitken, Z., Simpson, S., Neate, S. L., Taylor, K. L., O’Kearney, E., Bevens, W., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01074 · Cited by 40
Metadata
- Authors
- Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N.
- Affiliations
- University of Manitoba (CA)
- Scientific and Clinical Review Associates, LLC, USA
- Cleveland Clinic (US)
- Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA
- Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy
- Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark
- University of Alabama at Birmingham (US)
- Corresponding author
- Marrie, Ruth Ann
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2015-01-12
- Volume
- 21
- Issue
- 3
- Pages
- 305-317
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- PMC
- PMC4429164
- OpenAlex
- W2105913548
- Cited by
- 519
- References
- 136
- Citations by year
- 2026: 42 · 2025: 31 · 2024: 45 · 2023: 46 · 2022: 52 · 2021: 68 · 2020: 48 · 2019: 38 · 2018: 43 · 2017: 47 · 2016: 43 · 2015: 16
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Multiple Sclerosis Journal (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- mediaTUM (Technical University of Munich) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- U.S. Department of Defense
- National Multiple Sclerosis Society
- Pfizer
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- Cleveland Clinic
- Multiple Sclerosis Society of Canada
- Multiple Sclerosis Society
- MedDay Pharmaceuticals
- National Institutes of Health
- Genentech
- EMD Serono
- National Heart, Lung, and Blood Institute
- National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, psychiatric comorbidity, depression, anxiety, alcohol abuse, bipolar disorder, substance abuse, psychosis, incidence, prevalence, quality of life, fatigue
- MeSH terms
- Mental Disorders, Humans, Multiple Sclerosis, Comorbidity, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
